Collagen and Gut Health: What the Research Shows — A Pharmacist's Evidence Review
CEO & Lead Pharmacist, Khang Pharmacy • CA/MN/TX Licensed Pharmacist
Clinical Insights Series • APhA Immunization Certified • 10+ Years Clinical Experience
The Clinical Question
Collagen is the most abundant protein in the human body and the primary structural protein in skin, bones, tendons, ligaments, and the extracellular matrix underlying the intestinal lining. The evidence for collagen supplementation in joint health is now moderately strong. For skin, pooled analyses suggest benefits, but a 2025 meta-analysis found these benefits were not significant among non-industry-funded or higher-quality trials — making the skin evidence more conflicted than older reviews implied. For gut health and intestinal permeability, the biological rationale is plausible, but human evidence remains limited and a directly relevant randomized trial was largely negative. This article reviews what the research actually shows.
Collagen and Skin Health — Mixed and Conflicted Evidence
- HUMAN RCT PMID 23949208 — Proksch et al., skin elasticity: Double-blind RCT (n=69 women); 2.5 g or 5 g/day specific collagen peptides for 8 weeks. Skin elasticity improved significantly vs. placebo. Effects on skin moisture did not reach statistical significance overall.
- HUMAN RCT PMID 36916504 — 2023 RCT, skin hydration and wrinkling: 100 women aged 30–60; 1,650 mg/day hydrolyzed collagen for 12 weeks. Significant improvements vs. placebo reported for hydration, wrinkling, desquamation, and elasticity at various time points.
- HUMAN RCT PMID 33774639 — 2021 RCT, skin water content: 99 women randomized to 1 g, 5 g, or placebo for 12 weeks. Collagen increased skin water content and natural moisturizing factor and reduced transepidermal water loss. Elasticity did not significantly change. Useful as a counterbalance to studies showing only positive elasticity outcomes.
- META-ANALYSIS PMID 33742704 — de Miranda et al., 2021 (19 studies, 1,125 participants): Favorable pooled effects on hydration, elasticity, and wrinkle reduction; heterogeneity among included studies noted.
- META-ANALYSIS PMID 37432180 — Pu et al., 2023 (26 RCTs, 1,721 participants): Hydrolyzed collagen significantly improved pooled skin hydration and elasticity. Authors identified biases in included studies and called for larger, more rigorous RCTs.
- META-ANALYSIS PMID 40324552 — Myung et al., 2025 (23 RCTs, 1,474 participants) — Critical caveat: Overall pooling suggested improvements in hydration, elasticity, and wrinkles. However, when stratified by funding source, non-industry-funded trials showed no significant benefit, and high-quality studies did not show significant benefit across evaluated skin outcomes. The authors concluded that current clinical evidence does not support collagen supplements for preventing or treating skin aging. This is the most methodologically current analysis available. Grade: CONFLICTED / INDUSTRY-FUNDING CONCERN.
Overall skin grade: MIXED / CONFLICTED — pooled analyses show improvements in hydration, elasticity, and wrinkles, but a 2025 meta-analysis found these benefits were not significant among non-industry-funded or higher-quality trials, and the authors concluded the current evidence does not support collagen for preventing or treating skin aging.
Collagen and Joint Health — Moderate-to-Strong Evidence
- META-ANALYSIS PMID 38218227 — 2024 trial-sequential meta-analysis (35 RCTs, 3,165 patients): Collagen derivatives produced small-to-moderate pain improvement (SMD −0.35) and functional improvement (SMD −0.31) vs. control. Moderate certainty for pain; high certainty for function. No increased risk of adverse events or withdrawal. Authors concluded accumulated evidence supported efficacy and safety of collagen derivatives for osteoarthritis. Grade: MODERATE-TO-STRONG / SUPPORTIVE.
- META-ANALYSIS PMID 39212129 — 2024 updated knee-OA meta-analysis (11 RCTs, 870 participants): Collagen significantly improved both pain and function. Heterogeneity was high (I² 88% for pain, 75% for function). Grade: MODERATE / SUPPORTIVE — heterogeneity limits confidence.
- META-ANALYSIS PMID 29018060 — Liu et al., 2018 (69 randomized trials, 20 supplements): Collagen hydrolysate showed a clinically important short-term effect on OA pain. Evidence quality varied; long-term efficacy was less certain.
- HUMAN RCT PMID 27852613 — Shaw et al., collagen synthesis biomarker: Small randomized crossover (n=8); 15 g vitamin C-enriched gelatin before exercise increased a blood marker of collagen synthesis. This study measured a biomarker, not clinical joint pain.
Eggshell Membrane — Ingredient-Level Evidence
- HUMAN RCT PMID 19340512 — eggshell membrane, knee OA (n=67): 500 mg/day natural eggshell membrane vs. placebo for 8 weeks. Significant responses for pain and stiffness including early improvement by day 10. Function and overall WOMAC scores did not significantly improve.
- HUMAN RCT PMID 32633648 — eggshell membrane, knee OA (n=150): 75 eggshell membrane vs. 75 placebo; 300 mg/day for 12 weeks. Some KOOS pain and daily-function outcomes favored eggshell membrane, though not every pain endpoint differed from placebo.
Grade for eggshell membrane: LIMITED–MODERATE / SUPPORTIVE for selected knee-OA pain and stiffness outcomes. Not established for joint function or overall WOMAC in all trials.
Collagen and Gut Health — Preclinical Rationale; Limited Human Evidence
The intestinal epithelial barrier is maintained by tight-junction complexes including claudins, occludin, and ZO-1. Collagen is an important component of the underlying extracellular matrix and basement membrane. The biological rationale for collagen supporting gut-barrier function is plausible but human clinical evidence remains limited and the most directly relevant human randomized trial was largely negative.
- PRECLINICAL — IN VITRO PMID 28174772 — Chen et al., Caco-2 cell study: Alaska pollock-derived collagen peptides attenuated TNF-α-induced barrier dysfunction and affected tight-junction-related pathways (ZO-1, occludin, NF-κB) in Caco-2 monolayers. Cell-culture research only — cannot establish that oral collagen improves intestinal permeability in humans.
- PRECLINICAL — MECHANISTIC REVIEW PMID 12612130 — Glycine and intestinal inflammation: Glycine, collagen’s most abundant amino acid, has demonstrated anti-inflammatory effects on intestinal mucosa in preclinical models including NF-κB inhibition. Human RCT data on glycine’s effect on gut permeability is limited.
- HUMAN RCT — LARGELY NEGATIVE PMID 36370176 — Human randomized crossover trial, exercise-induced permeability: 20 volunteers received collagen peptides 10 g/day or placebo for 7 days before a strenuous 70-minute running protocol. Researchers directly measured intestinal permeability (lactulose/rhamnose ratio), intestinal injury (I-FABP), LPS, inflammatory markers, and GI symptoms. Collagen peptides did not significantly improve any of these outcomes vs. placebo. LPS increased after exercise in control but not collagen — investigators considered this hypothesis-generating only. Grade: LIMITED / NEGATIVE-TO-INCONCLUSIVE.
- HUMAN PILOT — OPEN-LABEL PMID 35639457 — Digestive symptoms, uncontrolled pilot: Healthy women received 20 g/day collagen peptides for 8 weeks. Among completers, some digestive symptoms including bloating appeared to improve. Critical limitations: single arm, open-label, no placebo, only 14 of 40 participants completed the study. Cannot support conclusions about efficacy. Grade: PRELIMINARY / INSUFFICIENT TO ESTABLISH EFFICACY.
Overall gut-health grade: Intestinal-barrier mechanisms — PRECLINICAL / MECHANISTIC. Human intestinal permeability — LIMITED / NEGATIVE-TO-INCONCLUSIVE. Digestive symptoms — PRELIMINARY HUMAN PILOT EVIDENCE ONLY. IBS/IBD treatment and “leaky gut” treatment — NOT ESTABLISHED.
Evidence Summary
Knee OA pain/function — MODERATE–STRONG / SUPPORTIVE (PMID 38218227 primary)
Skin hydration/elasticity/wrinkles — MIXED / CONFLICTED — pooled analyses positive; non-industry-funded and high-quality trials not significant (PMID 40324552)
Eggshell membrane / knee OA — LIMITED–MODERATE / SUPPORTIVE for pain & stiffness
Collagen synthesis after exercise — LIMITED / BIOMARKER EVIDENCE ONLY
Intestinal-barrier mechanisms — PRECLINICAL / MECHANISTIC
Human intestinal permeability — LIMITED / NEGATIVE-TO-INCONCLUSIVE (PMID 36370176)
Digestive symptoms — PRELIMINARY HUMAN PILOT EVIDENCE
IBS/IBD treatment by collagen — NOT ESTABLISHED
“Leaky gut” treatment — NOT ESTABLISHED
Bacillus coagulans GI effects — STRAIN-SPECIFIC — cannot transfer without strain identification
Ancient Nutrition finished product — NOT DIRECTLY ESTABLISHED
What Is Intestinal Permeability?
The gut lining is designed to be selectively permeable — allowing nutrients into the bloodstream while keeping bacteria, undigested particles, and bacterial endotoxins out. Disruption of tight junctions can allow these substances to enter circulation, potentially triggering systemic inflammation. Increased intestinal permeability has been documented in association with IBD, celiac disease, and type 2 diabetes, though the causal direction is often unclear. “Leaky gut syndrome” as a clinical diagnosis remains debated in conventional medicine.
The 5 Types of Collagen
- Type I: Most abundant — skin, bones, tendons, extracellular matrix. Primary collagen for skin elasticity and structural support.
- Type II: Found primarily in cartilage. Most studied for joint health and arthritis support.
- Type III: Found alongside Type I in skin and blood vessels.
- Type IV: Found in basement membranes beneath epithelial cells, including the intestinal epithelium.
- Type V: Found in cell surfaces and hair.
Featured Product: Ancient Nutrition Multi Collagen Protein Joint & Mobility
Ancient Nutrition Multi Collagen Protein Joint & Mobility (212g)
5 types of collagen from 4 whole food sources: hydrolyzed bovine hide (Types I & III), fermented eggshell membrane (Type V), chicken bone broth protein (Type II), and hydrolyzed fish collagen peptides (Type I). Plus: Vitamin C (100% DV), organic fermented turmeric, organic fermented ginger, and Bacillus coagulans (2 Billion CFU). Gluten-free, dairy-free, keto-friendly.
PharmD note: The joint-health evidence base for collagen derivatives is now moderately strong (see PMID 38218227, 35 RCTs). The eggshell membrane ingredient has small dedicated RCTs for knee OA pain, though functional outcomes were less consistent. The formula also contains Bacillus coagulans — probiotic evidence is strain-specific, and the specific strain in this product has not been confirmed; clinical effects of generic B. coagulans cannot be assumed. Evidence for collagen as a gut-barrier or “leaky gut” treatment remains preliminary. Patients with fish or egg allergies should review the ingredient list before use.
Drug Interactions
- Generally well-tolerated — collagen peptides have no significant known drug interactions at standard doses.
- Fish allergy: Contains hydrolyzed fish collagen — contraindicated in fish allergy.
- Egg allergy: Contains fermented eggshell membrane — consult pharmacist if egg-allergic.
- Kidney disease: High-protein supplements should be used with caution in significant renal impairment. Consult your nephrologist or pharmacist.
- Warfarin: No significant interaction documented at standard doses.
Who May Consider Collagen Supplementation?
- Adults with joint pain or osteoarthritis — strongest and most consistent human evidence base
- Adults 35+ interested in skin elasticity or hydration support — some individual RCTs show benefit, but the overall evidence base is more conflicted than older meta-analyses suggested, particularly regarding funding effects
- Active individuals and athletes with connective tissue demands
- Adults interested in gut-health support — while acknowledging that collagen has not been established to treat IBS, IBD, or increased intestinal permeability, and the most relevant human permeability trial was negative
Pharmacist’s Perspective
As a PharmD, I discuss collagen most often in the context of joint health, where the evidence is now moderately strong. For skin, individual RCTs show promising results, but the 2025 meta-analysis finding that non-industry-funded and higher-quality trials did not show significant benefit is an important caveat that I share with patients. For gut health, the biological rationale is sound but the human evidence is limited and includes a directly relevant negative randomized trial. The evidence does not support collagen as a treatment for leaky gut, IBS, or IBD. Patients with significant gut concerns warrant evaluation by a gastroenterologist. Free PharmD consultation: (408) 622-8068.
Frequently Asked Questions
Q: How long does collagen take to work for joint or skin benefits?
A: Most clinical trials assessed supplementation over 8–12 weeks or longer; results should not be expected immediately.
Q: Can I take collagen with my probiotic?
A: Yes — Ancient Nutrition Multi Collagen already includes Bacillus coagulans.
Q: Is collagen vegetarian or vegan?
A: Most collagen is animal-derived (bovine, marine, chicken, egg). Vegan “collagen boosters” contain precursor nutrients but not actual collagen. Ancient Nutrition Multi Collagen is not vegan.
Q: Does collagen help with leaky gut?
A: The biological mechanism is plausible, but human clinical evidence is limited. The most directly relevant human randomized trial (PMID 36370176) found that collagen peptides did not significantly improve measured intestinal permeability or gut injury biomarkers. We do not currently have RCT evidence establishing collagen as a treatment for intestinal permeability in humans.
Related Clinical Insights Articles
FDA Disclaimer
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Collagen is a dietary supplement. The information provided is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
Reviewed by:
Dai Tran, PharmD, MBA, B.S. • View full bio →
CEO & Lead Pharmacist, Khang Pharmacy • CA/MN/TX Licensed • 10+ Years Clinical Experience
Khang Pharmacy | 2451 S King Rd., Ste A1, San Jose, CA 95122 | (408) 622-8068 | www.khangpharmacy.com
